Using an innovative approach to tumor research, the Clinical Proteomic Tumor Analysis Consortium (CPTAC), founded by the National Cancer Institute, studied over 1,000 tumor samples from 10 different cancer types. The results generated a vast amount of data that will improve our understanding of cancer’s mechanisms, thereby paving the way for advancements in pan-cancer treatment […]